These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19638539)

  • 1. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
    J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Malago M; Steveling K; Reis H; Cicinnati VR; Schmid KW; Baba HA
    J Hepatol; 2008 Jan; 48(1):83-90. PubMed ID: 17998146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma.
    Gianni S; Cecchetto A; Altavilla G; Ragazzi R; Bertazzo M; De Giorgio M; Baldan A; Fagiuoli S; Farinati F
    J Intern Med; 2005 Apr; 257(4):367-73. PubMed ID: 15788007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinoma.
    Baba HA; Wohlschlaeger J; Cicinnati VR; Hilgard P; Lang H; Sotiropoulos GC; Takeda A; Beckebaum S; Schmitz KJ
    Liver Int; 2009 Mar; 29(3):399-405. PubMed ID: 18492014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma.
    Morinaga S; Tarao K; Yamamoto Y; Nakamura Y; Rino Y; Miyakawa K; Ohkawa S; Akaike M; Sugimasa Y; Takemiya S
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1249-55. PubMed ID: 17688665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of clusterin in human hepatocellular carcinoma.
    Kang YK; Hong SW; Lee H; Kim WH
    Hum Pathol; 2004 Nov; 35(11):1340-6. PubMed ID: 15668890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
    Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.
    Rikimaru T; Taketomi A; Yamashita Y; Shirabe K; Hamatsu T; Shimada M; Maehara Y
    Oncology; 2007; 72(1-2):69-74. PubMed ID: 18004079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
    Mitsuhashi N; Kobayashi S; Doki T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Miura S; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e189-97. PubMed ID: 18466288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma.
    Thelen A; Jonas S; Benckert C; Weichert W; Schott E; Bötcher C; Dietz E; Wiedenmann B; Neuhaus P; Scholz A
    Ann Surg Oncol; 2009 May; 16(5):1222-30. PubMed ID: 19224279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative plasma transcript AA454543 level is an independent prognostic factor for hepatocellular carcinoma after partial hepatectomy.
    Cheung ST; Liu CL; Chow JP; Lee YT; Ip YC; Ho JC; Fan ST
    Neoplasia; 2006 Sep; 8(9):696-701. PubMed ID: 16984726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
    Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
    Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.